Alvotech (ALVO)

Mar 12, 2026

Alvotech (NASDAQ:ALVO) Hits New 52-Week LowTime to Sell? - MarketBeat

Mar 12, 2026

Mar 12, 2026

Alvotech stock hits 52-week low at 3.65 USD - Investing.com Nigeria

Mar 12, 2026

Mar 12, 2026

Alvotech, Advanz Pharma get EU nod for Eylea biosimilar - MSN

Mar 12, 2026

Mar 11, 2026

Alvotech (ALVO) Projected to Post Earnings on Wednesday - MarketBeat

Mar 11, 2026

Mar 07, 2026

Will Alvotech stock attract ESG investorsCPI Data & AI Enhanced Trading Signals - Naître et grandir

Mar 07, 2026

Mar 05, 2026

Alvotech Stock Plummets to New 52-Week Low of $3.65 - Markets Mojo

Mar 05, 2026

Mar 04, 2026

ALVO Earnings History & Surprises | EPS & Revenue Results | ALVOTECH SA (NASDAQ:ALVO) - ChartMill

Mar 04, 2026

Mar 04, 2026

Alvotech to Release Fourth Quarter and Full Year 2025 Financial Results - geneonline.com

Mar 04, 2026

Mar 04, 2026

Alvotech to Announce Q4 and Full Year 2025 Financial Results on March 18, 2026 - Quiver Quantitative

Mar 04, 2026

Mar 04, 2026

Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Mar 04, 2026

Mar 03, 2026

Alvotech (ALVO) Stock Analysis: Exploring A Potential 375% Upside In The Biosimilar Market - DirectorsTalk Interviews

Mar 03, 2026

Mar 03, 2026

Alvotech : Managers' transactionsALVOTECH - marketscreener.com

Mar 03, 2026

Mar 03, 2026

Alvotech stock hits 52-week low at 3.89 USD By Investing.com - Investing.com South Africa

Mar 03, 2026

Mar 02, 2026

Alvotech’s Biosimilar Bet: Why Wall Street Is Suddenly Watching - AD HOC NEWS

Mar 02, 2026

Mar 02, 2026

Alvotech (ALVOW) Competitors - Meyka

Mar 02, 2026

Mar 02, 2026

Alvotech (NASDAQ:ALVO) Sets New 12-Month LowShould You Sell? - MarketBeat

Mar 02, 2026

Mar 02, 2026

Alvotech stock hits 52-week low at 3.89 USD - Investing.com

Mar 02, 2026

Mar 02, 2026

Alvotech (NASDAQ:ALVO) Given Average Recommendation of "Reduce" by Analysts - MarketBeat

Mar 02, 2026

Feb 27, 2026

Alvotech Discloses Intra-Group Transfer of 2.7 Million Shares Within Aztiq Group - TipRanks

Feb 27, 2026

Feb 27, 2026

Alvotech (NASDAQ: ALVO) discloses 2.7M-share intra-group transfer at $4.74 - Stock Titan

Feb 27, 2026

Feb 26, 2026

Transactions of Managers and Closely Associated Persons - GlobeNewswire

Feb 26, 2026

Feb 24, 2026

Alvotech (ALVO) Is Down 9.1% After FDA Rejects AVT05 Over Facility Issues and Legal Probe - simplywall.st

Feb 24, 2026

Feb 23, 2026

ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech - GlobeNewswire

Feb 23, 2026

Feb 21, 2026

Alvotech begins European rollout of first-ever Simponi biosimilar Gobivaz - MSN

Feb 21, 2026

Feb 21, 2026

Alvotech (NASDAQ:ALVO) Cut to Strong Sell at Zacks Research - Defense World

Feb 21, 2026

Feb 20, 2026

Alvotech (NASDAQ:ALVO) Rating Lowered to Strong Sell at Zacks Research - MarketBeat

Feb 20, 2026

Feb 19, 2026

Alvotech stock hits 52-week low at $4.31 amid challenging year - Investing.com Australia

Feb 19, 2026

Feb 19, 2026

Alvotech (NASDAQ:ALVO) Reaches New 1-Year LowHere's Why - MarketBeat

Feb 19, 2026

Feb 18, 2026

Alvotech (NASDAQ:ALVO) Trading Down 5.7%Here's Why - MarketBeat

Feb 18, 2026

Feb 17, 2026

Alvotech (ALVO): A 378% Upside Potential In The Biosimilar Market - DirectorsTalk Interviews

Feb 17, 2026

Feb 16, 2026

Is There Now an Opportunity in Alvotech (ALVO) After a 64% One-Year Share Price Slide? - simplywall.st

Feb 16, 2026

Feb 16, 2026

Is Alvotech (ALVO) Pricing Make Sense After A 64% One Year Share Price Slump - Yahoo Finance

Feb 16, 2026

Feb 16, 2026

Alvotech AVT80 Progress And Sandoz Deals Shape Biosimilar Outlook - Yahoo Finance

Feb 16, 2026

Feb 15, 2026

How Alvotech Equity Warrant stock performs during Fed tightening cyclesEarnings Overview Summary & Free Safe Capital Growth Stock Tips - mfd.ru

Feb 15, 2026

Feb 15, 2026

Can Alvotech Equity Warrant maintain its current growth rateQuarterly Trade Summary & Accurate Entry and Exit Point Alerts - mfd.ru

Feb 15, 2026

Feb 15, 2026

Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80 - Finviz

Feb 15, 2026

Feb 13, 2026

Can Alvotech be recession proofJuly 2025 EndofMonth & Weekly Watchlist for Consistent Profits - mfd.ru

Feb 13, 2026

Feb 13, 2026

12 Best Penny Stocks That Will Skyrocket - Insider Monkey

Feb 13, 2026

Feb 12, 2026

Is Alvotech the Next Big Biotech Rocket or Just Hype? Real Talk on This Viral Underdog Stock - AD HOC NEWS

Feb 12, 2026

Feb 12, 2026

How Alvotech (ALVO) Affects Rotational Strategy Timing - Stock Traders Daily

Feb 12, 2026

Feb 12, 2026

Alvotech’s AVT03 Biosimilar Gains European Approval - MSN

Feb 12, 2026

Feb 11, 2026

Alvotech resolves global patent disputes with Regeneron and Bayer over Eylea biosimilar - MSN

Feb 11, 2026

Feb 11, 2026

Assessing Alvotech (ALVO) Valuation After AVT80 Trial Success And New Sandoz Agreements - simplywall.st

Feb 11, 2026

Feb 11, 2026

Alvotech Increases Share Capital by $125,000 Through Issuance of 12.5 Million Ordinary Shares - Quiver Quantitative

Feb 11, 2026

Feb 11, 2026

Alvotech Announces Increase in Number of Own Shares - ChartMill

Feb 11, 2026

Feb 11, 2026

Alvotech (ALVO) Investor Outlook: Exploring a 331% Potential Upside in the Biosimilars Market - DirectorsTalk Interviews

Feb 11, 2026